WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Bioscience Neurolucida
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, September 26, 2007, 27(39):10508-10519; doi:10.1523/JNEUROSCI.3353-07.2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rezvani, K.
Right arrow Articles by De Biasi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rezvani, K.
Right arrow Articles by De Biasi, M.

 Previous Article  |  Next Article 

Cellular/Molecular
Nicotine Regulates Multiple Synaptic Proteins by Inhibiting Proteasomal Activity

Khosrow Rezvani,1 Yanfen Teng,1 David Shim,1 and Mariella De Biasi1,2,3

Departments of 1Neuroscience and 2Molecular Physiology and Biophysics and 3Graduate Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas 77030

Correspondence should be addressed to Mariella De Biasi, Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030. Email: debiasi{at}bcm.tmc.edu

Ubiquitination regulates the degradation, membrane trafficking, and transcription of proteins. At mammalian synapses, the ubiquitin–proteasome system (UPS) influences synaptic transmission and plasticity. Nicotine also has the ability to affect synaptic function via mechanisms that remain partially unknown. We found that nicotine, at concentrations achieved by smokers, reduced proteasomal activity, produced accumulation of ubiquitinated synaptic proteins, and increased total protein levels. In particular, a 24 h exposure to nicotine decreased proteasome-dependent degradation of the {alpha}7 nicotinic acetylcholine receptor (nAChR) subunit, as indicated by the accumulation of ubiquitinated {alpha}7. The same nicotine treatment increased the levels of the AMPA glutamate receptor subunit GluR1, the NMDA receptor subunit NR2A, the metabotropic receptor mGluR1{alpha}, the plasticity factor Homer-1A, and the scaffolding postsynaptic density protein PSD-95, whereas the levels of another scaffolding protein, Shank, were reduced. These changes were associated with an inhibition of proteasomal chymotrypsin-like activity by nicotine. The nAChR antagonist mecamylamine was only partially able to block the effects of nicotine on the UPS, indicating that nAChR activation does not completely explain nicotine-induced inhibition of proteasomal catalytic activity. A competition binding assay suggested a direct interaction between nicotine and the 20S proteasome. These results suggest that the UPS might participate in nicotine-dependent synaptic plasticity.

Key words: nicotine; nicotinic acetylcholine receptor; proteasome; ubiquitin; glutamate receptors; mecamylamine


Received Jan. 29, 2007; revised Aug. 13, 2007; accepted Aug. 13, 2007.

Correspondence should be addressed to Mariella De Biasi, Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030. Email: debiasi{at}bcm.tmc.edu






-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-